Sanara MedTech Inc. SMTI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.04% | 18.62% | 4.72% | 21.51% | 28.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.04% | 18.62% | 4.72% | 21.51% | 28.01% |
| Cost of Revenue | 2.27% | 4.83% | -16.66% | -5.91% | -3.55% |
| Gross Profit | 9.59% | 19.80% | 6.71% | 24.29% | 31.50% |
| SG&A Expenses | 15.11% | 14.39% | -0.72% | 7.08% | 3.57% |
| Depreciation & Amortization | -10.08% | -15.37% | 260.91% | -44.66% | -37.72% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.04% | 11.25% | 4.74% | 1.62% | 1.13% |
| Operating Income | -28.42% | 220.61% | 4.49% | 318.35% | 185.81% |
| Income Before Tax | -182.17% | 164.08% | -218.47% | 128.94% | 114.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -182.17% | 164.08% | -218.47% | 128.94% | 114.18% |
| Earnings from Discontinued Operations | 98.34% | 102.10% | 79.67% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 100.00% | -- | -96.05% | -84.13% |
| Net Income | 77.52% | 113.01% | -4.63% | -964.15% | 42.51% |
| EBIT | -28.42% | 220.61% | 4.49% | 318.35% | 185.81% |
| EBITDA | -24.45% | 112.81% | 20.58% | 1,582.61% | 277.12% |
| EPS Basic | 77.64% | 112.80% | -5.38% | -948.32% | 43.48% |
| Normalized Basic EPS | -180.43% | 162.17% | -48.67% | 136.34% | 114.24% |
| EPS Diluted | 76.39% | 111.37% | -5.38% | -914.87% | 43.91% |
| Normalized Diluted EPS | -183.38% | 160.22% | -48.67% | 135.14% | 113.73% |
| Average Basic Shares Outstanding | 0.58% | 1.59% | -0.68% | 1.52% | 1.70% |
| Average Diluted Shares Outstanding | -2.96% | 4.85% | -0.68% | 4.97% | 5.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |